10 July 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on six medicines.

Polatuzumab vedotin (Polivy) was accepted to treat a type of lymphoma in patients who have received previous treatment and are unsuitable for stem cell transplantation.

Read SMC press release